Inventiva
Inventiva is a France-based biopharmaceutical company that develops and commercializes oral small molecule therapies for the treatment of lysosomal storage disorders.
Business Model:
Revenue: $9.6M
Employees: 51-200
Industries / Tags:
Detailed Inventiva Information
Geographic Data
Address: 50 rue de Dijon
City: Daix
State: île-de-france
Zip: 21121
Country: FR
Financial Info
Stage:
post ipo debt
Raised Last:
$52M
Raised Total:$140M
Social
Metrics
3,479,189Website Global Rank
3,492Website Monthly Traffic
Twitter Followers
Description
Inventiva is a France-based biopharmaceutical company that develops and commercializes oral small molecule therapies for the treatment of lysosomal storage disorders.
Contact Phone:
Contact Email:
Inventiva went public on 7/10/2020 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/10/2020
IPO Valuation:
$550M
Ticker Symbol:
IVA
IPO Price:
$14.4/share
Amount Raised:
$108M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
